|
2003 Journal Article Identification and characterization of the hepatic stellate cell transferrin receptorBridle, Kim R., Crawford, Darrell H. G. and Ramm, Grant A. (2003). Identification and characterization of the hepatic stellate cell transferrin receptor. American Journal of Pathology, 162 (5), 1661-1667. doi: 10.1016/S0002-9440(10)64300-3 |
|
2003 Journal Article Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasisBridle, K. R., Frazer, D. M., Wilkins, S. J., Dixon, J. L., Purdie, D. M., Crawford, D. H. G., Subramaniam, V. N, Powell, L. W., Anderson, G. J. and Ramm, G. A. (2003). Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet, 361 (9358), 669-673. doi: 10.1016/S0140-6736(03)12602-5 |
|
2003 Journal Article Evidence for a sub-morphological inflammatory process in the liver in haemochromatosisBridle, K. R., Crawford, D. H. G., Fletcher, L. M., Smith, J. L., Powell, L. W. and Ramm, G. A. (2003). Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis. Journal of Hepatology, 38 (4), 426-433. doi: 10.1016/S0168-8278(02)00444-0 |
|
2002 Journal Article The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver diseaseLewindon, PJ, Pereira, TN, Hoskins, AC, Bridle, KR, Williamson, RM and Ramm, GA (2002). The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. American Journal of Pathology, 160 (5), 1705-1715. doi: 10.1016/S0002-9440(10)61117-0 |
|
2001 Journal Article Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosisBridle, Kim R., Crawford, Darrell H. G., Powell, Lawrie W. and Ramm, Grant A. (2001). Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis. Liver, 21 (2), 96-104. doi: 10.1034/j.1600-0676.2001.021002096.x |
|
2001 Conference Publication Hepatic expression of iron transporters in patients with hemochromatosis or hepatitis C virus infectionBrindle, K.R., Frazer, D.M., Crawford, D.H. and Ramm, G.A. (2001). Hepatic expression of iron transporters in patients with hemochromatosis or hepatitis C virus infection. 52th Annual Meeting of the American Association for the Study of Liver Diseases, Dallas, TX, United States, 9-13 November 2001. Hoboken, NJ, United States: John Wiley & Sons. |
|
2001 Journal Article HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancersYoung, J. P., Biden, K. G., Simms, L. A., Huggard, P. R., Karamatic, R., Eyre, H. J., Sutherland, G. R., Herath, N. I., Barker, M. A., Anderson, G. J., Fitzpatrick, D. R., Ramm, G. A., Jass, J. R. and Leggett, B. A. (2001). HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proceedings of the National Academy of Sciences of the United States of America, 98 (1), 265-270. doi: 10.1073/pnas.011415298 |
|
2001 Journal Article Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3Macdonald, G., Bridle, K. R., Ward, P. J., Walker, N. I., Houglum, K., George, D. K., Smith, J. L., Powell, L. W., Crawford, D. and Ramm, G. A. (2001). Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. Journal of Gastroenterology and Hepatology, 16 (6), 599-606. doi: 10.1046/j.1440-1746.2001.02445.x |
|
2000 Conference Publication Cystic fibrosis liver disease and liver biopsy: improved accuracy of assessment with dual samplingLewindon, P. J., Walker, N. I., Williamson, R., Smith, J. L., Pereira, T. N., Shepherd, R. W. and Ramm, G. A. (2000). Cystic fibrosis liver disease and liver biopsy: improved accuracy of assessment with dual sampling. Australian Gastroenterology Week 2000, Hobart, 18-21 Oct, 2000. Asia: Blackwell Science. |
|
1999 Journal Article Activation of pancreatic stellate cells in human and experimental pancreatic fibrosisHaber, P. S., Keogh, G. W., Apte, M. V., Moran, C. S., Stewart, N. L., Crawford, D. H. G., Pirola, R. C., McCaughan, G. W., Ramm, G. A. and Wilson, J. S. (1999). Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. American Journal of Pathology, 155 (4), 1087-1095. doi: 10.1016/S0002-9440(10)65211-X |
|
1999 Journal Article Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosisGeorge, D. Keith, Ramm, Grant A., Walker, Neal I., Powell, Lawrie W. and Crawford, Darrell H. G. (1999). Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis. Journal of Hepatology, 31 (1), 47-52. doi: 10.1016/S0168-8278(99)80162-7 |
|
1999 Journal Article HaemochromatosisCrawford, D. H. G. and RammGA (1999). Haemochromatosis. Trends in Endocrinology and Metabolism, 10 (1), 14-17. doi: 10.1016/S1043-2760(98)00103-9 |
|
1999 Conference Publication Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseasesRamm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 October,1999. Carlton, Vic: Blackwell Science Asia. |
|
1999 Conference Publication Evaluation of serum TIMP-1 collagen type IV and MMP-2 as markers of hepatic fibrogenesis in cystic fibrosis liverLewindon, P., Murphy, T. M., Pereira, T., Ramm, G. A., Shepherd, R. W. and Smith, J. L. (1999). Evaluation of serum TIMP-1 collagen type IV and MMP-2 as markers of hepatic fibrogenesis in cystic fibrosis liver. Australian Gastroenterology Week 1999, Brisbane, Australia, 4-8 October 1999. Carlton, Vic: Blackwell Science. |
|
1999 Conference Publication Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseasesRamm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. American Assoc. for the Study of Liver Diseases 50th Annual Meeting, Dallas, Texas, USA, 5 - 9 Nov, 1999. USA: W B Saunders Co.. |
|
1999 Conference Publication Activated hepatic stellate cells produce increased collagen type I in patients with cystic fibrosis liver diseaseSmith, J. L., Ramm, G. A., Lewindon, P. and Blanch, N. L. (1999). Activated hepatic stellate cells produce increased collagen type I in patients with cystic fibrosis liver disease. Basel, Switzerland, Oct 1999. Switzerland: Congress for Liver Disease. |
|
1999 Journal Article Genetics of hemochromatosisCullen, L. M., Anderson, G. J., Ramm, G. A., Jazwinska, E. C. and Powell, L. W. (1999). Genetics of hemochromatosis. Annual Review of Medicine, 50 (1), 87-98. doi: 10.1146/annurev.med.50.1.87 |
|
1999 Conference Publication Hepatic stellate cells and hepatic fibrogenesis in cystic fibrosis liver diseaseGreco, S., Lewindon, P., Ramm, G. A. and Shepherd, R. W. (1999). Hepatic stellate cells and hepatic fibrogenesis in cystic fibrosis liver disease. Thirteenth Annual North American Cystic Fibrosis Conference, Washington State Convention and Trade Cen., Seattle, Washington USA, 7 - 10 October, 1999. California, USA: Wiley-Liss. doi: 10.1002/(SICI)1099-0496(199909)28:19 |
|
1999 Conference Publication Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseasesRamm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. Bioiron'99, Sorrento Palace, Sorrento - Naples, Italy, 23 - 28 May 1999. Italy: SGC. |
|
1999 Conference Publication Hepatic fibrogenesis in cystic fibrosis liver diseaseBlanch, N. L., Bridle, K., Greco, S., Lewindon, P., Murphy, T. M., Pereira, T., Ramm, G. A., Shepherd, R. W., Smith, J. L. and Walker, N. I. (1999). Hepatic fibrogenesis in cystic fibrosis liver disease. 50th Annual Meeting and Postgraduate Conference, Dallas, Texas, Nov 1999. USA: Harcourt and Brace (WD Saunders). |
